• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T510
Device Problems Gradient Increase (1270); Material Perforation (2205)
Patient Problem Regurgitation, Valvular (2335)
Event Date 06/15/2018
Event Type  Injury  
Manufacturer Narrative
Citation: chezar-azerrad c et al.Iatrogenic atrial septal defect post mitral valve in valve implantation.Cardiovasc revasc med.2018 dec;19(8s):82-85.Doi: 10.1016/j.Carrev.2018.06.010.Epub 2018 jun 15.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without the return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a (b)(6) female patient with severe mitral regurgitation who underwent implant of a 27 mm medtronic hancock bioprosthetic valve (serial number not provided).Six months post implant, the patient presented with fever and chills and was hospitalized.During hospitalization, the patient reported having undergone a tooth extraction 10 days prior to admission and six blood culture tests came back positive for corynebacterium striatum.Transthoracic echocardiography exhibited no vegetations and no valvular dysfunction.The patient was diagnosed with endocarditis and was treated with vancomycin for 6 weeks.A follow-up echocardiogram showed mildly elevated gradients and no vegetations.Four months later, the patient presented with pulmonary edema and echocardiography revealed severe mitral regurgitation and a perforation of one of the valve leaflets.Subsequently, a 29 mm non-medtronic bioprosthetic valve was implanted valve-in-valve in the hancock.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8299041
MDR Text Key134845100
Report Number2025587-2019-00419
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 02/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberT510
Device Catalogue NumberT510
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/16/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-